लोड हो रहा है...
Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of Small Cell Lung Cancer
With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...
में बचाया:
| मुख्य लेखकों: | , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Chinês |
| प्रकाशित: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2019-04-01
|
| श्रृंखला: | Chinese Journal of Lung Cancer |
| विषय: | |
| ऑनलाइन पहुंच: | http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|